| Description | Rivabazumab pegol, a pegylated Fab antibody targeting the PcrV protein, is utilized in phase II studies for chronic Pseudomonas aeruginosa infections [1]. |
| molecular weight | N/A |
| CAS | 1613506-32-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |